SeaStar Medical Holding Corporation (ICU) NASDAQ
3.53
-0.11(-3.02%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.53
-0.11(-3.02%)
Currency In USD
Address
3513 Brighton Boulevard
Denver, CO 80216
United States of America (the)
Phone
844 427 8100
Sector
Healthcare
Industry
Biotechnology
Employees
19
First IPO Date
March 18, 2021
| Name | Title | Pay | Year Born |
| Eric Schlorff | Chief Executive Officer, Treasurer, President & Executive Director | 406,500 | 1973 |
| Michael Messinger | Chief Financial Officer | 30,000 | 1975 |
| H. David Humes | Co-Founder & Scientific Advisor | 135,713 | N/A |
| Colonel Kevin Chung FACP | Chief Medical Officer | 345,000 | 1974 |
| Sai Iyer | Senior Vice President of Medical Affairs & Research | 0 | N/A |
| Bradford K. Towne | Controller & Principal Accounting Officer | 0 | 1978 |
| Tim Varacek | Senior Vice President of Commercial & Business Operations | 0 | N/A |
| Tom Mullen | Vice President of Operations & Product Development | 0 | N/A |
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.